Many lawsuits have been filed around the country by individuals alleging that Paxil was a causative factor in their own or a loved one's serious suicide attempt or suicide. 

Baum Hedlund is one of the leading national law firms representing Paxil suicide and suicide attempt victims across the country. The firm represents approximately 50 victims.

Since 1990, Baum Hedlund has been handling antidepressant-SSRI (selective serotonin reuptake inhibitors) suicide/violence cases and served on the Plaintiffs' Steering Committee in the first SSRI-suicide litigation involving Prozac (the first SSRI approved by the FDA for marketing in the U.S.).

Several Baum Hedlund attorneys served as either Lead Counsel for, or as members of the Plaintiffs' Steering Committee (MDL-1574) Paxil Products Liability Litigation. 

In March of 2006, Baum Hedlund filed a national class action lawsuit against GlaxoSmithKline (GSK) for Paxil-induced suicides in youths.

Federal Judge Rules Against GSK and Allows Teenage Paxil Suicide Case to Go to Trial
Baum, Hedlund, Aristei & Goldman Achieves Third Preemption Win This Year on Behalf of Their Clients in a Paxil Suicide Case
Judge Approves $40 Million Settlement in Second Phase of National Pediatric Paxil Class Action - Insurance Companies to be Reimbursed
Federal Judge Reverses Preemption Ruling in Indiana Paxil Suicide Case
Kate Gillespie: Preparing for the Battle Over Paxil and Birth Defects
Baum Hedlund Wins Key Preemption Ruling in Collins Paxil Suicide Case
Child Born with Severe Heart Defects Sues Paxil-Maker
Judge Approves Final Terms of Improved National Pediatric Paxil Class Action Settlement - Consumers Get a Better Deal
National Class Action Filed Against Drug-Maker For Paxil-induced Suicides in Youths